Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Toward Zeptomole Proteomics in Cerebrospinal Fluid
12 May 2002. In the post-genome era, the next big challenge lies in mapping the proteome of every cell type, a daunting task indeed. One obstacle will be to identify trace amounts of proteins in cell or tissue samples. Time-of-flight mass spectroscopy, probably the biggest gun in the proteomics arsenal, is up to the task but can identify weakly expressed proteins only after they have been separated from the bulk of the sample. Because even partial purifications are time-consuming, and need to be tailored for every protein, this approach is not suitable for routine analysis. In this month's Nature Biotechnology, Ulf Landegren and colleagues at the Rudbeck Laboratory, Uppsala, Sweden, describe a method for the detection of zeptomole (yes, that's 10-21 mole) amounts of protein in cell culture medium without the need for purification. Ironically, this protein-sleuthing method depends on the DNA-amplifying polymerase chain reaction.

Fredriksson et al. use special oligonucleotides, called aptamers, to identify target proteins by a process that they label "proximity-dependent DNA ligation." Aptamers are DNA sequences that bind strongly and specifically to unique protein structures, essentially behaving like antibodies. The researchers engineered aptamers to have tails complementary to a second oligonucleotide that acts as matchmaker and brings two aptamers together, whereupon they can be permanently ligated. In theory, two aptamers will only bind in the presence of a protein dimer, the matchmaker, and a ligase. Oligonucleotide ligation can then be detected using the polymerase chain reaction.

The authors used the platelet-derived growth factor B chain dimer (PDGF-BB) to test their assay. Proximity-dependent DNA ligation was three orders of magnitude more sensitive than ELISA, detecting as little as 10-20 moles of protein. The assay was specific, (for example PDGF-AA did not cross-react), and detected the target in complex biological fluids (for example fetal calf serum or cerebrospinal fluid) without compromising sensitivity. Probes designed for human a-thrombin gave similar results, but this time the aptamers were designed to bind to different sites of the same molecule, showing that the technique can be made to work for protein monomers, as well.

The only downside, as discussed by Michael Famulok, University of Bonn, Germany, in an accompanying News and Views, is the difficulty of making this generally applicable given that specific aptamers must be found for every protein one wants to assay.-Tom Fagan.

Reference:

Fredriksson S, Gullberg M, Jarvius J, Olsson C, Pietras K, Gústafsdóttir SM, Ostman A, Landegren U. Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol. 2002 May ; 20(5):473-7. Abstract

Famulok M. Bringing picomolar protein detection into proximity. Nat Biotechnol. 2002 May;20(5):448-9. No abstract available. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad